About Gilead Sciences, Inc
Gilead Sciences, Inc., a research-based biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, and Atripla products for the treatment of human immunodeficiency virus (HIV) infection; Veklury, an injection for intravenous use, for the treatment of coronavirus disease 2019; and Epclusa, Harvoni, Vosevi, Vemlidy, and Viread for the treatment of liver diseases. It also offers Yescarta, Tecartus, Trodelvy, and Zydelig products for the treatment of hematology, oncology, and cell therapy patients. In addition, the company provides Letairis, an oral formulation for the treatment of pulmonary arterial hypertension; Ranexa, an oral formulation for the treatment of chronic angina; and AmBisome, a liposomal formulation for the treatment of serious invasive fungal infections. Gilead Sciences, Inc. has collaboration agreements with Arcus Biosciences, Inc.; Pionyr; Tizona; Tango Therapeutics, Inc.; Jounce Therapeutics, Inc.; Galapagos; Janssen; Japan Tobacco, Inc.; Gadeta; Bristol-Myers Squibb Company; Merck; and Novo Nordisk A/S. The company was founded in 1987 and is headquartered in Foster City, California. Address: 333 Lakeside Drive, Foster City, CA, United States, 94404
Gilead Sciences, Inc News and around…
Latest news about Gilead Sciences, Inc (GILD) common stock and company :
Antibody treatments made by Regeneron Pharmaceuticals Inc (NASDAQ: REGN) and Eli Lilly And Co (NYSE: LLY) are not likely to work against ...
Gilead Sciences (GILD) closed the most recent trading day at $68.57, moving +0.09% from the previous trading session.
Hood River, OR, based Investment company Northside Capital Management, LLC (Current Portfolio) buys Snowflake Inc, Datadog Inc, Procore Technologies Inc, Planet Labs PBC, Trane Technologies PLC, sells Vir Biotechnology Inc, Roblox Corp, Oracle Corp, Abbott Laboratories, Johnson & Johnson during the 3-months ended 2021Q4, according to the most recent filings of the investment company, Northside Capital Management, LLC.
Gilead (GILD) gets FDA approval for label expansion of Veklury for the treatment of non-hospitalized patients at high risk for COVID-19 disease progression.
Pre-open movers U.S. stock futures traded lower in early pre-market trade after the Dow Jones tumbled 450 points in the previous ...
TheFDA has approvedGilead Sciences Inc's(NASDAQ: GILD) Veklury (remdesivir) for non-hospitalized adult and ...
Gilead Sciences, Inc. (Nasdaq: GILD) today announced that the U.S. Food and Drug Administration (FDA) has granted expedited approval of a supplemental new drug application (sNDA) for Veklury® (remdesivir) for the treatment of non-hospitalized adult and adolescent patients who are at high risk of progression to severe COVID-19, including hospitalization or death. This approval expands the role of Veklury, which is the antiviral standard of care for the treatment of patients hospitalized with COVID-19. The expanded indication allows for Veklury to be administered in qualified outpatient settings that can administer daily intravenous (IV) infusions over three consecutive days. The FDA has also expanded the pediatric Emergency Use Authorization (EUA) of Veklury to include non-hospitalized pediatric patients younger than 12 years of age who are at high risk of disease progression.
Investors in Gilead Sciences Inc (GILD) saw new options begin trading this week, for the April 14th expiration. One of the key inputs that goes into the price an option buyer is willing to pay, is the time value, so with 83 days until expiration the newly trading contracts represent a possible opportunity for sellers of puts or calls to achieve a higher premium than would be available for the contracts with a closer expiration..
Investment company Corbenic Partners LLC (Current Portfolio) buys JPMorgan Ultra-Short Municipal Income ETF, WisdomTree Emerging Markets ex-State-Owned Enterpr, WisdomTree International Hedged Quality Dividend G, Salesforce.com Inc, Vanguard S&P 500 Growth ETF, sells Qualcomm Inc, SPDR Nuveen Bloomberg Short Term Municipal Bond ET, Amazon.com Inc, Schrodinger Inc, SmileDirectClub Inc during the 3-months ended 2021Q4, according to the most recent filings of the investment company, Corbenic Partne
Investors in Gilead Sciences Inc (GILD) saw new options begin trading this week, for the April 14th expiration. One of the key inputs that goes into the price an option buyer is willing to pay, is the time value, so with 83 days until expiration the newly trading contracts represent a potential opportunity for sellers of puts or calls to achieve a higher premium than would be available for the contracts with a closer expiration..
Tulsa, OK, based Investment company Gibraltar Capital Management, Inc. (Current Portfolio) buys Janus Henderson AAA CLO ETF, Coterra Energy Inc, Boeing Co, AAON Inc, Coca-Cola Co, sells PowerShares QQQ Trust Ser 1, General Dynamics Corp, Prudential Financial Inc, BTC iShares MSCI USA Min Vol Factor ETF, iShares Core Dividend Growth ETF during the 3-months ended 2021Q4, according to the most recent filings of the investment company, Gibraltar Capital Management, Inc..
Investment company Columbus Macro, LLC (Current Portfolio) buys SPDR Portfolio Short Term Corporate Bond ETF, PowerShares QQQ Trust Ser 1, iShares Core U.S.
For nearly two years now, the COVID-19 pandemic has created an unprecedented challenge to public health and healthcare systems around the world. It has also had a ripple effect on HIV services, rai...
Investment company Chapman Investment Management, LLC (Current Portfolio) buys Charles Schwab Corp, Tesla Inc, KLA Corp, Western Alliance Bancorp, Target Corp, sells Fidelity National Information Services Inc, Gilead Sciences Inc, Coca-Cola Co, Merck Inc, McDonald's Corp during the 3-months ended 2021Q4, according to the most recent filings of the investment company, Chapman Investment Management, LLC.
Key Takeaways Everest has signed a global licensing deal for an anti-viral Covid treatment being developed by Singapore’s ...
Investment company Members Capital Advisors Inc (Current Portfolio) buys Vanguard Short-Term Corporate Bond ETF, BTC BlackRock Short Maturity Bond ETF, Air Products & Chemicals Inc, General Dynamics Corp, Gilead Sciences Inc, sells iShares 1-3 Year Credit Bond ETF, iShares iBoxx USD Investment Grade Corporate Bond , Owl Rock Capital Corp, Wells Fargo, Analog Devices Inc during the 3-months ended 2021Q4, according to the most recent filings of the investment company, Members Capital Advisors Inc.
A study of some of the first breakthrough cases of COVID-19 caused by the highly infectious omicron variant found that booster shots of the mRNA vaccines failed to block that strain, although the infections involved only mild or moderate symptoms, confirming they are effective in preventing serious illness and death.
Failed efforts to contain COVID have come at huge economic, social and health costs.
Among the underlying components of the Russell 3000 index, we saw noteworthy options trading volume today in CrowdStrike Holdings Inc (CRWD), where a total of 24,921 contracts have traded so far, representing approximately 2.5 million underlying shares. That amounts to about 60.6% of CRWD's average daily trading volume over the past month of 4.1 million shares..
Symbols mentioned in this story: VONV, GILD, GM, CME Exchange traded funds (ETFs) trade just like stocks, but instead of ''shares'' investors are actually buying and selling ''units''. These ''units'' can be traded back and forth just like stocks, but can also be created or destroyed to accommodate investor demand..
In early trading on Wednesday, shares of Pinduoduo topped the list of the day's best performing components of the Nasdaq 100 index, trading up 4.9%. Year to date, Pinduoduo registers a 10.7% gain.
New York, NY, based Investment company Beech Hill Advisors, Inc. (Current Portfolio) buys Block Inc, The Walt Disney Co, Activision Blizzard Inc, Crown Castle International Corp, Gilead Sciences Inc, sells Delta Air Lines Inc, Broadcom Inc, L3Harris Technologies Inc, Exact Sciences Corp, Chewy Inc during the 3-months ended 2021Q4, according to the most recent filings of the investment company, Beech Hill Advisors, Inc..
Gilead Sciences Inc(NASDAQ: GILD) said an unauthorized network of drug distributors and suppliers sold pharmacies more than $250 ...
Gilead Sciences Inc said an unauthorized network of drug distributors and suppliers sold pharmacies more than $250 million of counterfeit versions of its HIV treatments over the last two years, endangering patients. The drugmaker said it found 85,247 bottles that had been tampered with or faked, including versions of its Biktarvy and Descovy treatments. In a separate statement on Wednesday, Gilead said it has seized the bottles of Gilead-labeled medication from 17 locations in nine states as part of its investigation.
Investment company Townsend & Associates, Inc (Current Portfolio) buys The AES Corp, ConocoPhillips, Huntsman Corp, Gilead Sciences Inc, AbbVie Inc, sells PowerShares QQQ Trust Ser 1, Morgan Stanley, Intuitive Surgical Inc, Apollo Global Management Inc, Union Pacific Corp during the 3-months ended 2021Q4, according to the most recent filings of the investment company, Townsend & Associates, Inc.
Gilead Sciences, Inc. (Nasdaq: GILD) announced today that its fourth quarter and full year 2021 financial results will be released on Tuesday, February 1, after the market closes. At 4:30 p.m. Eastern Time that day, Gilead’s management will host a webcast to discuss the company’s fourth quarter and full year 2021 financial results and will provide a business update.
Gilead Sciences uncovered a network that sold some $250 million of counterfeit versions of its HIV medications, a media report says.
Philadelphia, PA, based Investment company Addison Capital Co (Current Portfolio) buys Coterra Energy Inc, Intel Corp, General Motors Co, Activision Blizzard Inc, Match Group Inc, sells iShares S&P 500 Growth ETF, Peapack Gladstone Financial Corp, iShares S&P 500 Value ETF, BTC iShares Cohen & Steers REIT ETF, Medtronic PLC during the 3-months ended 2021Q4, according to the most recent filings of the investment company, Addison Capital Co.
Gilead Sciences Inc said on Tuesday that tampered and counterfeit versions of its HIV treatments worth $250 million were sold to pharmacies over two years by a network of drug distributors and suppliers. The drugmaker said in August that distributors not authorized by Gilead to sell its HIV treatments, Biktarvy and Descovy, have sold counterfeits to pharmacies where genuine Gilead bottles have been tampered with a counterfeit foil induction seal or label and contain incorrect tablets.